Marchex, Inc.
NASDAQ:MCHXAdvertising Agencies
+$0.03 today
- Market cap
- $51.59M
- Beta
- 1.89
- P/E (TTM)
- -13.4
- EPS (TTM)
- -$0.11
Volume 0.02M
Average 0.02M
MCHX Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Marchex, Inc.NASDAQ: MCHX
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation grows, but more slowly than its trailing trend
Q1 FY2026 stock-based compensation of $489K rose 7.5% year over year, behind the +40.0% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 7.2% from the prior quarter. Over 3 fiscal years it compounded at -3.4% a year.
Context
- Stock-based compensation amounted to 5.3% of revenue in FY2025, up 1.7 pp from a year earlier.
- Stock-based compensation increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +7.5% toward the trailing-twelve-month pace of +40.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 2.39M USD
- Year-over-year change
- +39.8%
- 4-year CAGR
- -2.8%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.39M | +39.8% |
| FY2024 | 2024-12-31 | 1.71M | -28.7% |
| FY2023 | 2023-12-31 | 2.39M | -9.6% |
| FY2022 | 2022-12-31 | 2.65M | -1.0% |
| FY2021 | 2021-12-31 | 2.67M | — |
Stock-Based Compensation vs competitors
How MCHX compares with its peers on the latest reported figures
- MCHX's LTM Mar 2026 stock-based compensation of $2.42M is the 3rd largest of the 7 companies compared; the peer median is $1.97M.
- Its year-over-year change of +40.0% is the highest of 6, against a peer median of -39.8%.
- Stock-based compensation amounts to 5.4% of revenue for MCHX, versus a peer median of 3.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $30.4M | -42.3% | +24.5% | 5.7% | |
| LTM Mar 2026 | $9.53M | -14.9% | +53.7% | 2.2% | |
| LTM Mar 2026 | $2.42M | +40.0% | -3.4% | 5.4% | |
| LTM Jun 2024 | $2.32M | — | +150.2% | 6.1% | |
| LTM Mar 2026 | $1.61M | -39.8% | +34.7% | 5.4% | |
| LTM Mar 2026 | $1.61M | -20.7% | +4.7% | 1.5% | |
| LTM Mar 2026 | $1.11M | -42.0% | -7.1% | 1.2% | |
| Peer median (excluding MCHX) | $1.97M | -39.8% | +29.6% | 3.8% | |
Competitors are the stored peer set for MCHX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (4.39M) | (8.25M) | (9.91M) | (4.95M) | (5.24M) |
| Depreciation & Amortization | 5.97M | 4.03M | 3.87M | 2.65M | 2.67M |
| Deferred Income Tax | (6K) | 43K | 0 | 330K | 86K |
| Stock-Based Compensation | 2.67M | 2.65M | 2.39M | 1.71M | 2.39M |
| Change in Working Capital | (6.4M) | (1.68M) | (1.57M) | (693K) | (2.13M) |
| Accounts Receivables | (2.13M) | (1.28M) | 360K | 469K | 309K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (1.05M) | 675K | (1.26M) | (566K) | 1.85M |
| Other Working Capital | (3.23M) | (1.07M) | (675K) | (596K) | (4.29M) |
| Other Non-Cash Items | (4.19M) | 906K | 819K | (147K) | 811K |
| Operating Cash Flow | (6.34M) | (2.29M) | (4.4M) | (1.1M) | (1.41M) |
| Capital Expenditures | (1.35M) | (2.87M) | (1.38M) | (429K) | (36K) |
| Acquisitions (Net) | 400K | 0 | 0 | 0 | 0 |
| Purchases of Investments | (400K) | 0 | 0 | 0 | 0 |
| Sales of Investments | 341K | 0 | 0 | 0 | 0 |
| Other Investing Activities | 59K | 0 | 65K | 0 | (1.28M) |
| Investing Cash Flow | (951K) | (2.87M) | (1.31M) | (429K) | (1.32M) |
| Debt Repayment | 0 | 0 | (185K) | (310K) | (397K) |
| Common Stock Issued | 528K | 40K | 25K | 3K | 300K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (1.5M) | 0 | 0 | 0 |
| Financing Cash Flow | 528K | (1.46M) | (160K) | (307K) | (97K) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (6.77M) | (6.61M) | (5.87M) | (1.84M) | (2.83M) |
| Free Cash Flow | (7.69M) | (5.16M) | (5.77M) | (1.53M) | (1.44M) |
Marchex, Inc.
NASDAQ:MCHX
Intrinsic Alpha fair value
Locked
Current Price
$1.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.